233 related articles for article (PubMed ID: 29722000)
1. Review of diagnostic, prognostic, and predictive biomarkers in melanoma.
Ankeny JS; Labadie B; Luke J; Hsueh E; Messina J; Zager JS
Clin Exp Metastasis; 2018 Aug; 35(5-6):487-493. PubMed ID: 29722000
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive biomarkers in melanoma: an update.
Foth M; Wouters J; de Chaumont C; Dynoodt P; Gallagher WM
Expert Rev Mol Diagn; 2016; 16(2):223-37. PubMed ID: 26620320
[TBL] [Abstract][Full Text] [Related]
4. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
[TBL] [Abstract][Full Text] [Related]
5. Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy).
Ascierto PA; Agarwala SS; Botti G; Budillon A; Davies MA; Dummer R; Ernstoff M; Ferrone S; Formenti S; Gajewski TF; Garbe C; Hamid O; Lo RS; Luke JJ; Michielin O; Palmieri G; Zitvogel L; Marincola FM; Masucci G; Caracò C; Thurin M; Puzanov I
J Transl Med; 2019 Jul; 17(1):234. PubMed ID: 31331337
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in melanoma.
Griewank KG
Scand J Clin Lab Invest Suppl; 2016; 245():S104-12. PubMed ID: 27467728
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers.
Abbas O; Miller DD; Bhawan J
Am J Dermatopathol; 2014 May; 36(5):363-79. PubMed ID: 24803061
[TBL] [Abstract][Full Text] [Related]
8. Emerging Biomarkers in Cutaneous Melanoma.
Eisenstein A; Gonzalez EC; Raghunathan R; Xu X; Wu M; McLean EO; McGee J; Ryu B; Alani RM
Mol Diagn Ther; 2018 Apr; 22(2):203-218. PubMed ID: 29411301
[TBL] [Abstract][Full Text] [Related]
9. [Molecular diagnosis of melanocytic tumors].
Bauer J
Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
[TBL] [Abstract][Full Text] [Related]
10. Revisiting determinants of prognosis in cutaneous melanoma.
Weiss SA; Hanniford D; Hernando E; Osman I
Cancer; 2015 Dec; 121(23):4108-23. PubMed ID: 26308244
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis.
Jiang Y; Shi X; Zhao Q; Krauthammer M; Rothberg BE; Ma S
Genomics; 2016 Jun; 107(6):223-30. PubMed ID: 27141884
[TBL] [Abstract][Full Text] [Related]
12. A review of advanced genetic testing for clinical prognostication in uveal melanoma.
Werdich XQ; Jakobiec FA; Singh AD; Kim IK
Semin Ophthalmol; 2013; 28(5-6):361-71. PubMed ID: 24010756
[TBL] [Abstract][Full Text] [Related]
13. Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma.
Van Laar R; Lincoln M; Fereday S
PLoS One; 2019; 14(2):e0211504. PubMed ID: 30721246
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Wu ZS; Cheng XW; Wang XN; Song NJ
Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases.
Su J; Yu W; Liu J; Zheng J; Huang S; Wang Y; Qi S; Ma X; Chen J; Zhang Y
Pathology; 2017 Dec; 49(7):740-749. PubMed ID: 29037804
[TBL] [Abstract][Full Text] [Related]
16. What's new in prognostication of melanoma in the dermatopathology laboratory?
Bangash HK; Romegialli A; Dadras SS
Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
[TBL] [Abstract][Full Text] [Related]
17. Tumor biomarkers in melanoma.
Ugurel S; Utikal J; Becker JC
Cancer Control; 2009 Jul; 16(3):219-24. PubMed ID: 19556961
[TBL] [Abstract][Full Text] [Related]
18. Germline determinants of clinical outcome of cutaneous melanoma.
Vogelsang M; Wilson M; Kirchhoff T
Pigment Cell Melanoma Res; 2016 Jan; 29(1):15-26. PubMed ID: 26342156
[TBL] [Abstract][Full Text] [Related]
19. [Molecular and immunohistochemical diagnostics in melanoma].
Schilling B; Griewank KG
Hautarzt; 2016 Jul; 67(7):511-8. PubMed ID: 27270408
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-12 expression is increased in cutaneous melanoma and associated with tumor aggressiveness.
Zhang Z; Zhu S; Yang Y; Ma X; Guo S
Tumour Biol; 2015 Nov; 36(11):8593-600. PubMed ID: 26040769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]